To provide a potential measurement device capable of keeping a temperature of a cell and/or a culture solution (in particular, a temperature of a cell) constant. Provided is a potential measurement device including a semiconductor substrate; a wiring layer on the semiconductor substrate; a first electrode on the wiring layer; and a second electrode configured to detect an action potential of a cell on the wiring layer. A temperature measurement unit is formed on the semiconductor substrate. A heat conduction unit and a plurality of wirings connected to the second electrode are formed in the wiring layer.

Various cell analysis systems of the present teachings can measure the electrical and metabolic activity of single, living cells with subcellular addressability and simultaneous data acquisition for between about 10 cells to about 500,000 cells in a single analysis. Various sensor array devices of the present teachings can have sensor arrays with between 20 million to 660 million ChemFET sensors built into a massively paralleled array and can provide for simultaneous measurement of cells with data acquisition rates in the kilohertz (kHz) range. As various ChemFET sensor arrays of the present teachings can detect chemical analytes as well detect changes in cell membrane potential, various cell analysis systems of the present teachings also provide for the controlled chemical and electrical interrogation of cells.

A method of measuring hematocrit is provided. The method for measuring hematocrit includes the following steps. A test strip is provided. The test strip includes a reaction region and a pair of electrodes disposed in the reaction region. A whole blood sample is entered to the reaction region. After the whole blood sample enters the reaction region, a plurality of sets of square wave voltages are intermittently applied to the pair of electrodes based on a square wave voltammetry method to obtain a plurality of feedbacks related to hematocrit. An interval between two adjacent sets of square wave voltages ranges from 0.1 seconds to 4 seconds. A feedback of an n-th set of square wave voltages is obtained to calculate a hematocrit value of the whole blood sample and n is a positive integer greater than 1. A hematocrit value is calculated according to the feedback.

A method for using saliva to measure at least one substance or physiological parameter of a human or animal subject may involve inserting a first end of a sensor into a handheld saliva testing device. The method may also involve receiving saliva from the subject on a second end of the sensor, moving the saliva from the second end of the sensor to the first end, and processing the saliva with the handheld saliva testing device to provide initial saliva data related to the at least one substance or physiological parameter of the subject. In some embodiments, the sensor remains inserted in the handheld device while the subject deposits saliva on the opposite, free end of the sensor.

An aerospace galley insert includes an oven defining therein an oven inner cavity for receiving food to be prepared and a fluid supply for supplying fluid comprising water or water vapour to the oven inner cavity. The galley also includes an exterior space, a heat pipe extending between the cavity and the exterior space, a first temperature sensor for detecting a first temperature in the cavity, a second temperature sensor for detecting a second temperature in the exterior space, and a third temperature sensor for detecting a third temperature of the heat pipe where it extends into the exterior space. The system also includes a control unit configured to determine an actual water vapour concentration in the oven inner cavity based on the first, second and third temperatures, and configured to control the fluid supply in order to adjust the actual water vapour concentration to a target water vapour concentration.

A method for operating a medical device includes activating a processor in the medical device in a low-power operating mode, measuring a first voltage level of the battery, applying at least one discharge pulse to the battery in response to the first voltage level of the battery being greater than a predetermined passivation minimum voltage threshold and less than a predetermined passivation maximum voltage threshold, measuring a second voltage level of the battery after the at least one discharge pulse, and operating the processor in the medical device in an increased-power operating mode to continue operation of the medical device only in response to the second voltage level being greater than or equal to a predetermined operating voltage threshold, the predetermined operating voltage threshold being greater than the predetermined passivation minimum voltage threshold and less than or equal to the predetermined passivation maximum voltage threshold.

The embodiments disclose an apparatus including a test cartridge configured for inserting into a reader, a sample insertion component coupled to the test cartridge a test sample, a heater device coupled to the test cartridge configured to heat to a predetermined temperature the test sample, a sensor array coupled to the test cartridge consisting of at least one electrochemical sensor for sensing analytes in a sample, a reader configured to gather test related data from the sensor array coupled to the test cartridge, an analyzer coupled to the reader configured for determining test results of each sensor in the sensor array and comparing all the test results for confirmation of a valid test and coherent results, a MCU (Microcontroller Unit) to perform main control and processing functions, and orchestrates all the functionality for the Reader, and a BLE Radio RF link between the MCU and an external processing system.

Methods and devices for quantifying creatinine in a test sample are provided. The test sample is contacted with a sensing composition to obtain a product comprising a hydantoin-transition metal complex and ammonia. The sensing composition comprises creatinine deaminase and a transition metal salt. The creatinine deaminase enzymatically reacts with creatinine to provide the N-methyl hydantoin and ammonia. The N-methyl hydantoin forms the hydantoin-transition metal complex with the transition salt. A potential difference is applied to the product to measure a current signal provided by the hydantoin-transition metal complex. Concentration of N-methyl hydantoin is obtained based on the measured current signal using a calibration equation. The concentration of N-methyl hydantoin is correlated with concentration of creatinine to quantify the creatinine in the test sample.

An exemplary urinalysis device for non-clinical use is described as having: a housing; a touchscreen on the housing; a test strip holder, which is removably, slidably engaged with the housing; at least two light emitting diode (LED) light sources, housed in the housing and including a white LED and a red-blue-green (RBG) LED; a camera module housed in the housing, both the plurality of LEDs and the camera module directed to an illumination and detection zone; a timer system; and/or a computational system in electronic communication with the plurality of LEDs, the camera module and the timer system, the computational system including a processor and a memory. Related methods and systems also are described.

This invention relates to a handheld mobile device which can analyze and measure whole blood, serum, urine or analytes which contain target agents such as mycotoxin, aflatoxin or cholera etc. with a easy to use reusable cartridge consisting of a cartridge head and cartridge body. The cartridge comprises four syringes, one of which being detachable. A waste reservoir is integrated with the syringes.